Shanghai Neoleading Pharmaceutical Co., Ltd. is a subsidiary of Shanghai Bocimed Pharmaceutical Co., Ltd. engaged in synthesis technology, which is committed to providing efficient and high-quality services and products to global innovative drug companies with the goal of rapid compliance delivery.

Focusing on the development and manufacturing of new drug molecular masonry processes for small molecules, peptides, and small nucleic acids, and the innovation and commercialization of synthesis processes for new drugs, Neoleading Pharma, by leveraging its technological strengths and globalized regulatory compliance system, is committed to helping its customers achieve low-cost, safe, green, and reliable commercial manufacturing and customized synthesis services of intermediates and APIs covering levels from kilogram to ton.

In the field of small nucleic acids, we can provide a variety of nucleoside products, modified nucleosides, phosphoramidite monomers, and molecular building blocks required for the development of new small-nucleic acid drugs, etc. We also provide FTE services, analytical and testing services, CMC services, and CDMO services for the process development of small molecules and peptide drugs.